Methods of using ehmt2 inhibitors in treating or preventing blood disorders
AssigneeEpizyme, Inc.
InventorsElayne PENEBRE, Veronica GIBAJA, Maria Alejandra RAIMONDI
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to a method of preventing or treating a blood disorder (e.g., sickle-cell disease) via administering an EHMT2 inhibitor compound disclosed herein or a pharmaceutical composition thereof to subjects in need thereof. The present disclosure also relates to the use of such compounds for research or other non-therapeutic purposes.
Claims32
A method of preventing or treating a blood disorder, the method comprising administering to a subject in need thereof a therapeutically effective amount of an EHMT2 inhibitor.
4-9. (canceled)
12-19. (canceled)
21-25. (canceled)
27-45. (canceled)
47-48. (canceled)
(canceled)
55-66. (canceled)
69-122. (canceled)
124-147. (canceled)
150-175. (canceled)
177-183. (canceled)
185-218. (canceled)
Dependencies are inferred from the claim text.